Kalm Therapeutics (Kalm Tx) is pleased to announce the appointment of Dr. Tomoko Maeda-Chubachi, M.D., Ph.D., as our Chief ...

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of ...

More than 39 million people around the world could die from antibiotic-resistant infections over the next 25 years, according to a study published in The Lancet.  The new study by the Global Research ...

London: GSK plc has announced positive headline results of MATINEE, the phase III clinical trial evaluating Nucala ...

Invasive meningococcal disease (IMD) is rare and most people survive.1 However, even with appropriate medical care, up to 1 in 10 patients who ...

With Prince Harry set to make his way to the UK in less than two weeks, his father King Charles is allegedly not thrilled ...

Study findings support tivozanib monotherapy for second-line treatment of certain patients with metastatic RCC, an expert ...

The Allergy & Clinical Immunology Society (ACIS) of Nigeria in association with Emerging Societies Program (ESP) is set to optimise allergy care at the first ever ...

AFL legend and current Swans CEO Tom Harley, and his podcaster wife Felicity said they “did not know enough” about ...

If you suffered losses exceeding $100,000 in Moderna between January 18, 2023 and June 25, 2024 and would like to discuss ...